• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS® PERIMOUNT MAGNA; HEART-VALVE, REPLACEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS® PERIMOUNT MAGNA; HEART-VALVE, REPLACEMENT Back to Search Results
Model Number 3300TFX21MM
Device Problem Torn Material (3024)
Patient Problems Aortic Regurgitation (1716); Aortic Valve Stenosis (1717)
Event Date 03/20/2018
Event Type  Injury  
Manufacturer Narrative
The subject device is not available for evaluation, as it was discarded by the hospital staff.The clinical observation was unable to be confirmed.The device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Although bioprosthetic valves have been proven to have excellent long term durability, failure does occur in a small number of valves.Failure of a bioprosthetic valve over time is more likely due to structural valve deterioration (svd) which occurs as a result of stenosis (from calcification or host tissue overgrowth), dehiscence, fibrosis, non-calcific degeneration and/or endocarditis.Based on the information received, the most likely root cause is patient's clinical condition that contributed to this event.Of note, the patient's has had multiple sings of infection.A manufacturing non-conformance was not identified.There was no indication or allegation of a device malfunction contributing to the event.The instructions for use (ifu) has been reviewed and no inadequacies were identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Structural deterioration is listed as a potential adverse event in the ifu.Edwards will continue to review and monitor all events through the use of edwards quality systems.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No further corrective or preventative actions are required at this time.
 
Event Description
It was reported via the implant patient registry that a 21mm bioprosthetic aortic valve, implanted for four (4) years and eight (8) months, was explanted due to aortic valve regurgitation and aortic stenosis.This (b)(6) year old male patient presented with an apparent infection in a prosthetic right knee three years post avr.He was found to have a strep mitis/oralis bacteremia with septic arthritis.He was treated appropriately with eventual resolution of his illness.Few months later, tee demonstrated an ejection fraction 65% with moderate aortic valve regurgitation and identification of 2 separate eccentric jets.There was no vegetation seen.Eight months after his resolved illness, he developed a dental infection which was treated.Following that he developed progressive shortness of breath and was extremely symptomatic.Follow-up tee demonstrated worsening aortic insufficiency.He has had negative blood cultures.Prior to his redo avr, he had an infected tooth pulled.He underwent redo avr with a 21mm 3300tfx valve, platelet gel application, dual catheter on-q pain pump insertion.Intraoperatively, the aorta was opened and the valve pathology was visualized.There was a 2mm hole in the right coronary leaflet and the adjacent left coronary leaflet had partially torn away from the supporting strut causing prolapse of this leaflet.Postoperatively, he was taken to the intensive care unit.On pod one, av paced with underlying bradycardia.A permanent pacemaker was placed on pod #2.On pod #6, he experience new afib and amiodarone was administered.He was later discharged home on pod#7.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS® PERIMOUNT MAGNA
Type of Device
HEART-VALVE, REPLACEMENT
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
one edwards way
irvine CA 92614
Manufacturer Contact
neil landry
1 edwards way
mle2
irvine, CA 92614
9492502289
MDR Report Key7508195
MDR Text Key108037906
Report Number2015691-2018-01813
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860057/S042
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Reporter Occupation Physician
Type of Report Initial
Report Date 04/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/10/2017
Device Model Number3300TFX21MM
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/19/2018
Date Device Manufactured04/26/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age79 YR
-
-